Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Return on Capital Employed (2018 - 2025)

Historic Return on Capital Employed for Puma Biotechnology (PBYI) over the last 8 years, with Q3 2025 value amounting to 0.29%.

  • Puma Biotechnology's Return on Capital Employed fell 300.0% to 0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.25% for FY2024, which is 100.0% down from last year.
  • Per Puma Biotechnology's latest filing, its Return on Capital Employed stood at 0.29% for Q3 2025, which was down 300.0% from 0.4% recorded in Q2 2025.
  • Over the past 5 years, Puma Biotechnology's Return on Capital Employed peaked at 0.4% during Q2 2025, and registered a low of 0.19% during Q1 2022.
  • For the 5-year period, Puma Biotechnology's Return on Capital Employed averaged around 0.14%, with its median value being 0.18% (2023).
  • Its Return on Capital Employed has fluctuated over the past 5 years, first surged by 4900bps in 2021, then tumbled by -2300bps in 2022.
  • Puma Biotechnology's Return on Capital Employed (Quarter) stood at 0.05% in 2021, then skyrocketed by 451bps to 0.18% in 2022, then skyrocketed by 55bps to 0.28% in 2023, then fell by -8bps to 0.26% in 2024, then increased by 13bps to 0.29% in 2025.
  • Its last three reported values are 0.29% in Q3 2025, 0.4% for Q2 2025, and 0.32% during Q1 2025.